Mandate

Vinge advised Ernström & C:o

December 02, 2017 M&A

Vinge has advised Ernström & C:o in conjunction with the investment and acquisition of shares in CellMark Investment.

Ernström is a Gothenburg-based investment company which is owned by the Hobohm Hielte family. CellMark is a global trading house within chemicals, paper, pulp, metals, packaging, recycling, energy and pharmaceuticals. Ernström has acquired almost one quarter of CellMark.

Vinge’s team consisted of responsible partner Olof Jisland together with associates Filip Öhrner, Daniel Lennartsson, André Isacson, Sara Strandberg, Filip Markhed and VDR assistant Sofie Sundin.

Related

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025

Vinge advises OsteoCentric on the public offer for Integrum

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025